GMED vs MMC · P/E 42, rev $1.55B vs P/E 22, rev $26.98B
Globus Medical (GMED) versus Marsh & McLennan Companies Inc (MMC) — a side-by-side from cached financials, not a winner call.
Globus Medical (GMED) is a medical devices company listed on US.
Marsh & McLennan Companies Inc (MMC) is a insurance brokers company listed on US.
Latest reported GMED revenue for 2026-06-30 was $1.55B. Net income was $275.9M. GMED currently screens at market cap $7.66B and trailing P/E 42.1.
Latest reported MMC revenue for 2025-12-31 was $26.98B. Net income was $4.16B. Revenue was up 10.3% from 2024-12-31 to 2025-12-31. MMC currently screens at market cap $89.82B and trailing P/E 21.9.
GMED currently screens at market cap $7.66B and trailing P/E 42.1. MMC currently screens at market cap $89.82B and trailing P/E 21.9.
Not investment advice. Open the GMED and MMC stock pages for the full models.
Not investment advice.